A multicentre phase II trial of bryostatin-1 in patients with advanced renal cancerSrinivasan Madhusudan, Adrian L. Harris, A. Turner et al.|British Journal of Cancer|2003Cited by 48
Telomere maintenance mechanisms in malignant peripheral nerve sheath tumors: expression and prognostic relevanceLorenza Venturini, Nadia Zaffaroni, Maria Grazia Daidone et al.|Neuro-Oncology|2012Cited by 27
High level of telomerase RNA gene expression is associated with chromatin modification, the ALT phenotype and poor prognosis in liposarcomaClaire J. Cairney, W. Nicol Keith, S F Hoare et al.|British Journal of Cancer|2008Cited by 26
213 A Phase Ii Study of Etanercept (ENBREL), A Tumour Necrosis Factor-Alpha Inhibitor in Recurrent Ovarian CancerSrinivasan Madhusudan, Trivadi S. Ganesan, S. Muthuramalingam et al.|International Journal of Gynecological Cancer|2004Cited by 1